1,029 filings
Page 23 of 52
S-1MEF
rl2nl7lya96 8p
8 Jun 18
Registration of additional securities for an S-1
6:10am
EFFECT
af02oxk7oi1 dx1c
8 Jun 18
Notice of effectiveness
12:15am
CORRESP
zskleeov
5 Jun 18
Correspondence with SEC
12:00am
CORRESP
blp6olowl3rg5 jx
5 Jun 18
Correspondence with SEC
12:00am
FWP
dkndir1
4 Jun 18
Free writing prospectus
12:00am
8-K
4cbz fdf5hbnlga87
1 Jun 18
Trovagene, Inc. Announces Reverse Stock Split
4:30pm
8-K
2zxay206
30 May 18
Submission of Matters to a Vote of Security Holders
4:28pm
UPLOAD
9pvfk ekttm086
18 May 18
Letter from SEC
12:00am
8-K
wqo6ac kdl8dc30uao3m
17 May 18
Trovagene Announces Completion of First Dosing Cohort of Patients in Ongoing Phase 1b/2 Trial of PCM-075 in Acute Myeloid Leukemia
8:24am
8-K
k127746p319u2s glvr
9 May 18
Trovagene Announces First Quarter 2018 Highlights and Financial Results
7:42am
8-K
v9ow ng50h7
17 Apr 18
Trovagene Presents Data at AACR Meeting 2018 on Pharmacodynamic and Tumor Biomarkers During Treatment withPCM-075 andLow-Dose Cytarabine
12:00am
8-K
h40sjed i41x
16 Apr 18
Other Events
12:00am
8-K
ey497104pjtmv0h
13 Apr 18
Trovagene Announces Presentations at the American Association for Cancer Research (AACR) Annual Meeting2018
12:00am
8-K
xwdid6ruji zi5a4xc
13 Apr 18
Other Events
12:00am